Apellis Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.16 | $69.69 M | -0.84 | 51 |
AKRO
Akero Therapeutics, Inc. |
$43.29 | $3.45 B | -11.55 | 63 |
AMLX
Amylyx Pharmaceuticals, Inc. |
$3.81 | $338.02 M | -0.86 | 123 |
BPMC
Blueprint Medicines Corporation |
$90.72 | $5.80 B | -84.79 | 649 |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $8.19 B | -16.47 | 355 |
DAWN
Day One Biopharmaceuticals, Inc. |
$8.12 | $823.00 M | -7.96 | 181 |
IMVT
Immunovant, Inc. |
$17.89 | $3.04 B | -6.83 | 207 |
INZY
Inozyme Pharma, Inc. |
$0.96 | $62.21 M | -0.6 | 67 |
MDGL
Madrigal Pharmaceuticals, Inc. |
$333.82 | $7.37 B | -15.25 | 528 |
MREO
Mereo BioPharma Group plc |
$2.37 | $73.19 M | -7.88 | 33 |
MRTX
Mirati Therapeutics, Inc. |
$58.70 | $4.12 B | -4.82 | 587 |
RXDX
Prometheus Biosciences, Inc. |
$199.92 | $9.56 B | -56.47 | 97 |
TERN
Terns Pharmaceuticals, Inc. |
$3.10 | $270.19 M | -2.76 | 59 |
XFOR
X4 Pharmaceuticals, Inc. |
$0.27 | $46.70 M | -3.36 | 143 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
